Meldonium (dihydrate) - HY-B1836A
Nur noch %1 verfügbar
Catalog #
HY-B1836A
Ab
33,00 €
Meldonium (MET-88) dihydrate functions as a cardioprotective agent by cpmpetetively inhibiting γ-butyrobetaine hydroxylase (BBOX) and carnitine/organic cation transporter type 2 (OCTN2). Mildronate dihydrate exhibits IC50 values of 34-62 μM for human recombinant BBOX and an EC50 of 21 μM for human OCTN2. Meldonium dihydrate is a fatty acid oxidation inhibitor[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B1836A/Meldonium-dihydrate-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| Alternative Names | MET-88 (dihydrate); Quaterin (dihydrate) |
| CAS | 86426-17-7 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 182.22 |
| Solubility | DMSO : 4.85 mg/mL (ultrasonic;warming;adjust pH to 4 with HCl;heat to 60°C)|H2O : 100 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Mitochondrial Metabolism |
| Application: | COVID-19-immunoregulation |
|---|